Please note that masks must still be worn within NYOH practices regardless of vaccination status.
Learn more about this and other COVID-19 related updates

Clinical Trials & Research

Biomarker Advcd Uro Cancer and FGFR Aber

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

Disease Types: Bladder,&nbs

Available at: {clinical_trial_location backspace="7"}Biomarker Advcd Uro Cancer and FGFR Aber, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}